. 2015 Oct 19;2015:416838. doi: 10.1155/2015/416838

Table 5.

Evaluation of a genetic test for response to IFX after 1 year of treatment of the CD patients with concomitant use of immunomodulators.

Factor	Number of CD patients (%)		OR (95% CI)	P value^∗
	Responders	Nonresponders
	n = 20	n = 8
Both G/G genotype of rs766748 in IL17F and C/C and C/A genotype of rs1883136 in TRAF3IP2	14 (70.0)	0 (0)	37.92 (1.890–761.1)	0.0019
Others	6 (30.0)	8 (100)	37.92 (1.890–761.1)	0.0019

^∗Factors were statistically analyzed by Fisher's exact test.

IFX: infliximab; CD: Crohn's disease; OR: odds ratio; CI: confidence interval.